InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Hastings David C, 董事. Insider active across 3 companies, notably Entasis Therapeutics Holdings Inc.. In total, 11 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €71k. History available since 18 January 2022. The latest transaction was disclosed on 26 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
HASTINGS DAVID C is Administrateur at SCYNEXIS INC and Entasis Therapeutics Holdings Inc., and Chief Financial Officer at Arbutus Biopharma Corp. He has 11 filings in total. Across the 11 most recent filings available, the period runs from 2022-01-19 to 2026-06-30, with EUR 0 of purchases and EUR 70518 of sales, and the most frequent transaction nature is Attribution.